Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibitors Selective for Mycobacterial Versus Human Proteasomes

Journal Article · · Nature (London)

Many anti-infectives inhibit the synthesis of bacterial proteins, but none selectively inhibits their degradation. Most anti-infectives kill replicating pathogens, but few preferentially kill pathogens that have been forced into a non-replicating state by conditions in the host. To explore these alternative approaches we sought selective inhibitors of the proteasome of Mycobacterium tuberculosis. Given that the proteasome structure is extensively conserved, it is not surprising that inhibitors of all chemical classes tested have blocked both eukaryotic and prokaryotic proteasomes, and no inhibitor has proved substantially more potent on proteasomes of pathogens than of their hosts. Here we show that certain oxathiazol-2-one compounds kill non-replicating M.?tuberculosis and act as selective suicide-substrate inhibitors of the M.?tuberculosis proteasome by cyclocarbonylating its active site threonine. Major conformational changes protect the inhibitor-enzyme intermediate from hydrolysis, allowing formation of an oxazolidin-2-one and preventing regeneration of active protease. Residues outside the active site whose hydrogen bonds stabilize the critical loop before and after it moves are extensively non-conserved. This may account for the ability of oxathiazol-2-one compounds to inhibit the mycobacterial proteasome potently and irreversibly while largely sparing the human homologue.

Research Organization:
Brookhaven National Laboratory (BNL) National Synchrotron Light Source
Sponsoring Organization:
Doe - Office Of Science
DOE Contract Number:
AC02-98CH10886
OSTI ID:
980274
Report Number(s):
BNL--93192-2010-JA
Journal Information:
Nature (London), Journal Name: Nature (London) Vol. 461; ISSN NATUAS; ISSN 0028-0836
Country of Publication:
United States
Language:
English

Similar Records

Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome
Journal Article · Mon Dec 26 23:00:00 EST 2016 · Biochemistry · OSTI ID:1409607

Trypanosoma Cruzi Cyp51 Inhibitor Derived from a Mycobacterium Tuberculosis Screen Hit
Journal Article · Tue Feb 17 23:00:00 EST 2009 · PLoS Neglect Trop. D. · OSTI ID:1005471

Fellutamide B is a Potent Inhibitor of the Mycobacterium tuberculosis Proteasome
Journal Article · Thu Dec 31 23:00:00 EST 2009 · Archives of Biochemistry and Biophysics · OSTI ID:1019724